Welcome to our dedicated page for CNA FINANCIAL SEC filings (Ticker: CNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNA FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNA FINANCIAL's regulatory disclosures and financial reporting.
CNA Financial insider activity shows Executive Chairman and Director Dino E. Robusto selling common stock under a preset trading plan. On 12/01/2025, he sold 6,250 shares of CNA Financial common stock at a price of $46.92 per share, reported as a disposition in Table I. After this sale, he beneficially owned 668,088.061 shares directly.
The filing explains that this transaction was executed under a trading plan adopted on November 15, 2024, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934. Such plans allow insiders to schedule trades in advance, helping separate personal trading decisions from the timing of material nonpublic information.
CNA Financial Corp insider plans additional stock sale under Rule 144. A holder intends to sell 6,250 shares of CNA common stock through Fidelity Brokerage Services on or about 12/01/2025 on the NYSE, with an indicated aggregate market value of $293,250.00. CNA had 270,665,399 common shares outstanding for context.
The shares to be sold were acquired on 03/15/2023 through vesting of a performance share plan. Over the prior three months, the same seller completed three separate sales of 6,250 CNA shares each, with gross proceeds of $306,250.00 on 09/02/2025, $289,062.50 on 10/01/2025, and $283,000.00 on 11/03/2025. The seller represents that they are not aware of undisclosed material adverse information about CNA’s current or prospective operations.
CNA Financial (CNA) reported an insider transaction by its SVP & Chief Accounting Officer. On 11/12/2025, the officer reported a Code G transaction, indicating a bona fide gift of 900 shares of common stock at $0.
Following the transaction, the officer reported 21,371 shares beneficially owned, held in direct ownership. The filing was made by a single reporting person and shows no derivative securities activity.
CNA Financial Corporation filed a Form 13F holdings report, listing 12 positions with a Form 13F Information Table value total of $169,764,925.
The report identifies 3 other included managers: Loews Corporation, The Continental Corporation, and Continental Casualty Company. The filing states assets are described as having shared investment discretion among these entities, with each disclaiming ownership except for securities it beneficially owns. As of 9/30/2025, Loews owned approximately 92% of CNA; CNA owned 100% of The Continental Corporation; and The Continental Corporation owned 100% of Continental Casualty Company.
The report was signed by Amy Smith, Senior Vice President and Chief Accounting Officer, in Chicago, IL on 11-14-2025.
CNA Financial (CNA) Executive Chairman and Director Dino E. Robusto reported an open-market sale of 6,250 shares of common stock at $45.28 on November 3, 2025.
The transaction was made under a Rule 10b5-1(c) trading plan adopted on November 15, 2024. After the sale, Robusto beneficially owned 674,338.061 shares, held directly.
CNA Financial (CNA) filed a Form 3 reporting initial beneficial ownership by its SVP & General Counsel. As of 10/29/2025, the reporting person directly owned 8,385 shares of common stock. Table II shows no derivative securities listed. The filing indicates it was submitted by one reporting person.
CNA Financial (CNA) — Form 144 notice of proposed sale. Dino Robusto filed to sell up to 6,250 shares of CNA common stock with an aggregate market value of $283,000. The filing lists Fidelity Brokerage Services as broker and the NYSE as the exchange, with an approximate sale date of 11/03/2025.
The shares were acquired through vesting of PSP on 03/15/2023, in the amount of 6,250. The notice also lists recent sales for the account holder over the past three months: 6,250 shares on 08/04/2025 for $281,250; 6,250 shares on 09/02/2025 for $306,250; and 6,250 shares on 10/01/2025 for $289,062.50. Shares outstanding were 270,665,399. A Form 144 is a notice under Rule 144 and outlines a planned sale by an affiliate.
CNA Financial reported stronger Q3 2025 results as underwriting and investment performance improved. Total revenues were $3,817 million versus $3,618 million a year ago. Net earned premiums rose to $2,783 million, and net investment income was $638 million, while net investment losses were $7 million. Net income increased to $403 million, with diluted EPS of $1.48 compared with $1.04.
Catastrophe losses, net of reinsurance, were $41 million versus $143 million a year ago. Total comprehensive income was $778 million, down from $993 million, reflecting lower other comprehensive income. On the balance sheet, total investments reached $50.5 billion and stockholders’ equity rose to $11,322 million, with accumulated other comprehensive loss improving to $(1,211) million from $(1,991) million.
Year to date, operating cash flow was $1,920 million. The company paid $923 million in dividends and repurchased 700,000 shares for $34 million. Net prior year reserve development was $190 million unfavorable for the nine months, including $134 million in Corporate & Other largely tied to legacy mass tort abuse claim activity.
CNA Financial announced board leadership changes. Dino E. Robusto’s tenure as Executive Chairman and director will end on December 31, 2025, in accordance with his Employment Agreement dated June 5, 2024. The company appointed Douglas M. Worman, its President and Chief Executive, as Chairman of the Board, effective January 1, 2026.
The Board of Directors also approved a reduction in its size to ten, effective January 1, 2026. These updates centralize the CEO and Chairman roles with Mr. Worman and set the board’s composition for the new year.
CNA Financial Corporation filed a current report describing how it shared its third quarter 2025 results. On November 3, 2025, the company issued a press release and posted a financial supplement, earnings presentation and prepared earnings remarks on its website to explain its results of operations for the third quarter of 2025.
These materials are included with the report as exhibits but are designated as “furnished” rather than “filed,” which limits their use under certain securities laws. The filing itself does not repeat the financial figures, instead directing investors to the press release and related documents for detailed quarterly performance information.